Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
March 20, 2026 Drug delivery / Pharma applications

Special issue: New Insights into Cyclodextrin-Based Drug Delivery Systems

In recent decades, the biomedical and pharmaceutical potential of cyclodextrins has expanded remarkably. Their well‑established host–guest complexation ability continues to

Continue reading

March 19, 2026 CD as API / CD derivatives / Pharma applications

Evaluation of the Potential Therapeutic Effects of HPβCD and SBEβCD in a Mouse Model of Acute Ulcerative Colitis

A Nanjing, China based research group designed a tailored investigation [1] based on a surprising previous study [2]. In they

Continue reading

March 18, 2026 CD as API / CD derivatives / Pharma applications

HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke

Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona

Continue reading

March 20, 2026 Drug delivery / Pharma applications

Special issue: New Insights into Cyclodextrin-Based Drug Delivery Systems

In recent decades, the biomedical and pharmaceutical potential of cyclodextrins has expanded remarkably. Their well‑established host–guest complexation ability continues to

Continue reading

March 19, 2026 CD as API / CD derivatives / Pharma applications

Evaluation of the Potential Therapeutic Effects of HPβCD and SBEβCD in a Mouse Model of Acute Ulcerative Colitis

A Nanjing, China based research group designed a tailored investigation [1] based on a surprising previous study [2]. In they

Continue reading

March 18, 2026 CD as API / CD derivatives / Pharma applications

HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke

Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona

Continue reading

pexels-photo-30620861.jpeg
March 17, 2026 CD derivatives / Non-pharma applications / Other industrial use

Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application

Hewlett-Packard has developed a multi-fluid kit for three-dimensional printing, comprising:– a fusing agent including: – an electromagnetic energy absorber; and

Continue reading

March 16, 2026 CD as API / Pharma applications

HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment

Several North-American Universities worked together to find hydroxzpropyl-alpha-cyclodextrin(HPaCD) for the treatment of Krabbe disease. The deficiency of β-galactosylceramidase causes a

Continue reading

March 13, 2026 Events / Food / Non-pharma applications

Innovations in Food Science and Human Nutrition

The 11th Edition of Innovations in Food Science and Human Nutrition (IFHN-2026) conference is scheduled to take place on July

Continue reading

March 12, 2026 Food / Non-pharma applications

Cyclodextrins open way for aqueous extraction of phlorotannins producing extracts with improved stability during gastrointestinal transit

Phlorotannins have gained significant attention as functional supplements because of their potential bioactive and functional properties. Phlorotannins are, however, highly

Continue reading

March 11, 2026 CD derivatives / Life sciences

Obituary for Prof. Dr.-Ing. Wolfram Saenger

Prof. Dr.-Ing. Wolfram Saenger passed away on 16 February 2026. He was a German biochemist and protein scientist renowned for

Continue reading

March 10, 2026 CD as API / CD derivatives / Pharma applications

Toxic effects and cellular uptake of functional polyrotaxanes. The little we have learned and the many unknowns still waiting to be discovered.

Cyclodextrins are commonly used as excipients in modern drug delivery, but they also have a less common role as active

Continue reading

March 9, 2026 CD derivatives / Drug delivery / Pharma applications

Oral Treatment of Obesity by GLP-1 and Its Analogs

Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics

Continue reading

Posts pagination

1 2 3 … 194 Next Posts»

Recent Posts

  • Special issue: New Insights into Cyclodextrin-Based Drug Delivery Systems
  • Evaluation of the Potential Therapeutic Effects of HPβCD and SBEβCD in a Mouse Model of Acute Ulcerative Colitis
  • HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke
  • Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (337)
  • CD derivatives (390)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (766)
  • E-ducation (63)
  • Environmental (128)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (388)
  • Other industrial use (103)
  • Pharma applications (1,149)
  • Supramolecular systems (39)
  • Uncategorized (140)

Top Posts

  • Evaluation of the Potential Therapeutic Effects of HPβCD and SBEβCD in a Mouse Model of Acute Ulcerative Colitis
  • Special issue: New Insights into Cyclodextrin-Based Drug Delivery Systems
  • Lanosterol eye drops for cataract treatment
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • Renal safety of SBECD
  • The mechanism of ototoxicity studied by using HPBCD
  • Obituary for Prof. Dr.-Ing. Wolfram Saenger
  • Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • More and more manipulated results in Alzheimer and Parkinson’s research

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...